Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
SBC Medical Group Holdings ( (SBC) ) just unveiled an update.
On December 13, 2025, SBC Medical Group Holdings announced the final results of its tender offer for Waqoo, Inc., a Japanese medical R&D company specializing in regenerative medicine. The tender offer, conducted from November 14 to December 12, 2025, resulted in SBC Medical acquiring 575,052 shares at ¥1,900 per share. This acquisition, along with an off-market transaction with Waqoo’s largest shareholder, will increase SBC Medical’s ownership to over 50%, making it the parent company and largest shareholder of Waqoo. This strategic move enhances SBC’s healthcare technology capabilities and strengthens its presence in the Japanese market.
The most recent analyst rating on (SBC) stock is a Buy with a $4.00 price target. To see the full list of analyst forecasts on SBC Medical Group Holdings stock, see the SBC Stock Forecast page.
Spark’s Take on SBC Stock
According to Spark, TipRanks’ AI Analyst, SBC is a Outperform.
SBC Medical Group Holdings’ overall stock score is driven by strong valuation and positive corporate events, despite technical challenges and operational concerns. The strategic acquisition of Waqoo, Inc. is a significant positive factor, while the stock’s current technical indicators suggest caution.
To see Spark’s full report on SBC stock, click here.
More about SBC Medical Group Holdings
SBC Medical Group Holdings Incorporated is a comprehensive medical group operating across various medical fields, including advanced aesthetic medicine, dermatology, orthopedics, fertility treatment, dentistry, hair restoration, and ophthalmology. The company manages a diverse portfolio of clinic brands and is expanding its global presence, particularly in the United States and Asia, through direct operations and medical tourism initiatives. Listed on Nasdaq in September 2024, SBC Medical Group was included in the Russell 3000® Index in June 2025.
Average Trading Volume: 51,936
Technical Sentiment Signal: Hold
Current Market Cap: $428.8M
For a thorough assessment of SBC stock, go to TipRanks’ Stock Analysis page.